Treatment of Alcohol Withdrawal Syndrome with Gabapentin

U. Bonnet; M. Banger; F. M. Leweke; M. Maschke; T. Kowalski; M. Gastpar

doi:10.1055/s-2007-979203

Subscribe to RSS

Please copy the URL and add it into your RSS Feed Reader.

https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000054.xml

Share / Bookmark

Facebook X Linkedin Weibo

Download PDF

Pharmacopsychiatry 1999; 32(3): 107-109
DOI: 10.1055/s-2007-979203

Original Papers

Treatment of Alcohol Withdrawal Syndrome with Gabapentin

U. Bonnet¹ , M. Banger¹ , F. M. Leweke² , M. Maschke¹ , T. Kowalski¹ , M. Gastpar¹

¹Department of Psychiatry and Psychotherapy, University of Essen, Essen, Germany
²Department of Psychiatry, Heinrich Heine University, Düsseldorf, Germany

Further Information

Publication History

Publication Date:
20 April 2007 (online)

Also available at

PDF Download Permissions and Reprints

Abstract

Four in-patients with moderate alcohol-withdrawal syndromes benefited from treatment with gabapentin administered in an add-on fashion to clomethiazole. In comparison with the amount of clomethiazole required as estimated using a specially developed score during previous detoxifications of these patients at our hospital, gabapentin (400 mg q.i.d.) clearly reduced the amount of clomethiazole needed now Gabapentin, an anticonvulsant with favorable pharmacokinetic properties and tolerability, and with no known risk of dependence, may therefore be a useful new drug in the treatment of alcohol withdrawal. We believe that the potential value of gabapentin in alcohol withdrawal deserves further controlled studies.